// App-Quantinova.ai

4408 : Selective Splenic Artery Embolization for the Treatment of Thrombocytopenia and Hypersplenism in Paroxysmal Nocturnal Hemoglobinuria (PNH)

Researchers

Presenter

  • Karen Brown

Principal Investigators

  • David J. Araten

  • Emilia Scalzulli

  • Giovanni Fernando Torelli

  • Maria Stefania De Propris

  • Corrado Girmenia

  • Filippo Maria Salvatori

  • Orly Zelig

  • Robin Foa

  • Lucio Luzzatto

Medical Centers

  • Hadassah Medical School, Jerusalem, Israel

  • Istituto Toscano Tumori, Florence, Italy

  • Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy

  • Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy

  • Sapienza University, Rome, Italy

Locations

  • Italy

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Paroxysmal nocturnal hemoglobinuria

  • Thrombocytopenia

  • Venous thrombosis

  • Sepsis

Biomarkers

  • N/A

Drug/Treatment

  • Eculizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved